Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yutiq 0.05 mg in Chronic Non-Infectious Uveitis
NCT05070728Phase 3Terminated
- Sponsor
- EyePoint Pharmaceuticals
- Start
- Oct 2021
- Primary completion
- Apr 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluocinolone in chronic non-infectious uveitis, sponsored by EyePoint Pharmaceuticals. Started Oct 2021; status: terminated.
02
Drugs
fluocinolone
03
Conditions
chronic non-infectious uveitis
Beyond the preview
Go deeper on NCT05070728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05070728.